CA2493359A1 - Nouveau polymorphe de n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide et compositions et methodes associees - Google Patents
Nouveau polymorphe de n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide et compositions et methodes associees Download PDFInfo
- Publication number
- CA2493359A1 CA2493359A1 CA002493359A CA2493359A CA2493359A1 CA 2493359 A1 CA2493359 A1 CA 2493359A1 CA 002493359 A CA002493359 A CA 002493359A CA 2493359 A CA2493359 A CA 2493359A CA 2493359 A1 CA2493359 A1 CA 2493359A1
- Authority
- CA
- Canada
- Prior art keywords
- thienylcarbonyl
- pyrazol
- pyrimidin
- acetamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 230000004799 sedative–hypnotic effect Effects 0.000 abstract 1
- 229940125706 skeletal muscle relaxant agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40607202P | 2002-08-26 | 2002-08-26 | |
US60/406,072 | 2002-08-26 | ||
PCT/US2003/026870 WO2004018476A1 (fr) | 2002-08-26 | 2003-08-26 | Nouveau polymorphe de n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide et compositions et methodes associees |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2493359A1 true CA2493359A1 (fr) | 2004-03-04 |
CA2493359C CA2493359C (fr) | 2009-10-27 |
Family
ID=31946959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002493359A Expired - Lifetime CA2493359C (fr) | 2002-08-26 | 2003-08-26 | Nouveau polymorphe de n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide et compositions et methodes associees |
Country Status (32)
Country | Link |
---|---|
US (2) | US6903106B2 (fr) |
EP (1) | EP1532152B1 (fr) |
JP (2) | JP4522859B2 (fr) |
KR (1) | KR101063033B1 (fr) |
CN (1) | CN1319974C (fr) |
AP (1) | AP2005003220A0 (fr) |
AR (1) | AR044191A1 (fr) |
AT (1) | ATE343581T1 (fr) |
AU (1) | AU2003268212B2 (fr) |
BR (1) | BR0313695A (fr) |
CA (1) | CA2493359C (fr) |
DE (1) | DE60309332T2 (fr) |
DK (1) | DK1532152T3 (fr) |
EA (1) | EA200500421A1 (fr) |
EC (1) | ECSP055703A (fr) |
ES (1) | ES2274260T3 (fr) |
HK (1) | HK1071373A1 (fr) |
HR (1) | HRP20050288A2 (fr) |
IL (2) | IL166621A0 (fr) |
IS (1) | IS7769A (fr) |
MA (1) | MA27519A1 (fr) |
MX (1) | MXPA05002251A (fr) |
NO (1) | NO20050615L (fr) |
NZ (1) | NZ538027A (fr) |
OA (1) | OA12917A (fr) |
PE (1) | PE20040979A1 (fr) |
PL (1) | PL374436A1 (fr) |
PT (1) | PT1532152E (fr) |
TN (1) | TNSN05058A1 (fr) |
TW (1) | TWI288135B (fr) |
WO (1) | WO2004018476A1 (fr) |
ZA (1) | ZA200501125B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0313695A (pt) * | 2002-08-26 | 2005-06-21 | Neurocrine Biosciences Inc | Polimorfo de n-metil-n-(3-{3-[2-tienil carbonil]pirazol-[1,5-alfa]pirimidin-7-il}fenil) acetamida e composições e processos relacionados ao mesmo |
US7429596B2 (en) * | 2003-06-20 | 2008-09-30 | The Regents Of The University Of California | 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof |
WO2006044903A1 (fr) * | 2004-10-18 | 2006-04-27 | Neurocrine Biosciences, Inc. | Hydrate du n-méthyl-n-(3-{3-[2-thiénylcarbonyl]pyrazol-[1,5-α]-pyrimidin-7-yl}phényl)acétamide et procédés et méthodes s'y rapportant |
CN100528875C (zh) * | 2005-02-18 | 2009-08-19 | 美德(江西)生物科技有限公司 | 无结晶型态的印地普隆及其制备方法 |
EP1918290A1 (fr) * | 2006-10-11 | 2008-05-07 | Ferrer Internacional, S.A. | La polymorphe B de la N-{2-fluoro-5-[3-thiophèn-2-carbonyle)-pyrazolo[1,5-a]pyrimidin-7-yl]-phènyl}-N-methyle-acetamide |
EP1956021A1 (fr) * | 2006-10-11 | 2008-08-13 | Ferrer Internacional, S.A. | Procédé de préparation d'un pyrazole[1,5-a]pyrimidine en forme crystalline |
CN102180879B (zh) * | 2006-11-09 | 2013-05-01 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种催眠药的多晶型α的乙酸溶剂化物 |
CN101177427B (zh) * | 2006-11-09 | 2011-07-20 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物 |
CN102834987B (zh) | 2010-03-25 | 2015-04-15 | 矢崎总业株式会社 | 接头连接器和用于识别接头连接器中的汇流条图案的方法 |
EP2377830B1 (fr) * | 2010-04-16 | 2016-04-13 | Ivoclar Vivadent AG | Vitrocéramique et verre à base du silicate de lithium ayant d'oxyde de métal de transition |
PL2672847T3 (pl) | 2011-02-11 | 2015-10-30 | Batmark Ltd | Część składowa inhalatora |
AT510837B1 (de) | 2011-07-27 | 2012-07-15 | Helmut Dr Buchberger | Inhalatorkomponente |
CN102174048B (zh) * | 2011-03-08 | 2014-09-17 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种催眠药的新多晶型β |
RU2595971C2 (ru) | 2011-09-06 | 2016-08-27 | Бритиш Америкэн Тобэкко (Инвестментс) Лимитед | Нагревание курительного материала |
GB201207039D0 (en) | 2012-04-23 | 2012-06-06 | British American Tobacco Co | Heating smokeable material |
GB2533135B (en) | 2014-12-11 | 2020-11-11 | Nicoventures Holdings Ltd | Aerosol provision systems |
GB201511349D0 (en) | 2015-06-29 | 2015-08-12 | Nicoventures Holdings Ltd | Electronic aerosol provision systems |
US11924930B2 (en) | 2015-08-31 | 2024-03-05 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
US20170055584A1 (en) | 2015-08-31 | 2017-03-02 | British American Tobacco (Investments) Limited | Article for use with apparatus for heating smokable material |
US20170119046A1 (en) | 2015-10-30 | 2017-05-04 | British American Tobacco (Investments) Limited | Apparatus for Heating Smokable Material |
KR20210009450A (ko) | 2016-04-27 | 2021-01-26 | 니코벤처스 트레이딩 리미티드 | 전자 에어로졸 제공 시스템 및 전자 에어로졸 제공 시스템을 위한 증기화기 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472528B1 (en) | 1999-08-10 | 2002-10-29 | Neurocrine Biosciences, Inc. | Synthesis of substituted pyrazolopyrimidines |
US6399621B1 (en) * | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
US6485746B1 (en) * | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6384221B1 (en) * | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
IL148242A0 (en) * | 1999-09-02 | 2002-09-12 | Neurocrine Biosciences Inc | Polymorphs of n-methyl-n(3-(3-[2 thienylcarbonyl] pyrazol-[1, 5-a]-pyrimidin-7-yl} phenyl) acetamide, pharmaceutical compositions containing the same and processes for the preparation thereof |
JP2001177971A (ja) * | 1999-12-20 | 2001-06-29 | Auto Network Gijutsu Kenkyusho:Kk | 回転接続装置 |
BR0313695A (pt) * | 2002-08-26 | 2005-06-21 | Neurocrine Biosciences Inc | Polimorfo de n-metil-n-(3-{3-[2-tienil carbonil]pirazol-[1,5-alfa]pirimidin-7-il}fenil) acetamida e composições e processos relacionados ao mesmo |
-
2003
- 2003-08-26 BR BR0313695-7A patent/BR0313695A/pt not_active Application Discontinuation
- 2003-08-26 NZ NZ538027A patent/NZ538027A/en not_active IP Right Cessation
- 2003-08-26 ES ES03749163T patent/ES2274260T3/es not_active Expired - Lifetime
- 2003-08-26 CN CNB03820245XA patent/CN1319974C/zh not_active Expired - Fee Related
- 2003-08-26 KR KR1020057003193A patent/KR101063033B1/ko active IP Right Grant
- 2003-08-26 MX MXPA05002251A patent/MXPA05002251A/es active IP Right Grant
- 2003-08-26 PL PL03374436A patent/PL374436A1/xx not_active Application Discontinuation
- 2003-08-26 CA CA002493359A patent/CA2493359C/fr not_active Expired - Lifetime
- 2003-08-26 PE PE2003000867A patent/PE20040979A1/es not_active Application Discontinuation
- 2003-08-26 PT PT03749163T patent/PT1532152E/pt unknown
- 2003-08-26 EA EA200500421A patent/EA200500421A1/ru unknown
- 2003-08-26 US US10/648,812 patent/US6903106B2/en not_active Expired - Lifetime
- 2003-08-26 OA OA1200500060A patent/OA12917A/en unknown
- 2003-08-26 EP EP03749163A patent/EP1532152B1/fr not_active Expired - Lifetime
- 2003-08-26 IL IL16662103A patent/IL166621A0/xx unknown
- 2003-08-26 DK DK03749163T patent/DK1532152T3/da active
- 2003-08-26 JP JP2004531248A patent/JP4522859B2/ja not_active Expired - Fee Related
- 2003-08-26 DE DE60309332T patent/DE60309332T2/de not_active Expired - Lifetime
- 2003-08-26 AU AU2003268212A patent/AU2003268212B2/en not_active Ceased
- 2003-08-26 AP AP2005003220A patent/AP2005003220A0/xx unknown
- 2003-08-26 WO PCT/US2003/026870 patent/WO2004018476A1/fr active IP Right Grant
- 2003-08-26 TW TW092123478A patent/TWI288135B/zh not_active IP Right Cessation
- 2003-08-26 AT AT03749163T patent/ATE343581T1/de active
- 2003-08-27 AR ARP030103086A patent/AR044191A1/es not_active Application Discontinuation
-
2004
- 2004-12-15 US US11/013,308 patent/US7459458B2/en not_active Expired - Lifetime
-
2005
- 2005-02-01 IL IL166621A patent/IL166621A/en active IP Right Review Request
- 2005-02-03 NO NO20050615A patent/NO20050615L/no not_active Application Discontinuation
- 2005-02-08 ZA ZA200501125A patent/ZA200501125B/en unknown
- 2005-02-25 MA MA28122A patent/MA27519A1/fr unknown
- 2005-02-25 TN TNP2005000058A patent/TNSN05058A1/en unknown
- 2005-03-23 EC EC2005005703A patent/ECSP055703A/es unknown
- 2005-03-23 IS IS7769A patent/IS7769A/is unknown
- 2005-03-24 HR HR20050288A patent/HRP20050288A2/xx not_active Application Discontinuation
- 2005-05-26 HK HK05104433A patent/HK1071373A1/xx not_active IP Right Cessation
-
2009
- 2009-12-22 JP JP2009291164A patent/JP2010070561A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2493359A1 (fr) | Nouveau polymorphe de n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide et compositions et methodes associees | |
CA2191647A1 (fr) | Amelioration du procede de synthese de n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide | |
SG170783A1 (en) | Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis | |
WO2006105372A3 (fr) | Alkynyle pyrrolopyrimidines et analogues associes en tant qu'inhibiteurs de hsp90 | |
HK1043366A1 (en) | Synthesis of a substituted pyrazolopyrimidine | |
CA2417875A1 (fr) | Polymorphes de zaleplon et procedes de preparation de ceux-ci | |
CA2382588A1 (fr) | Polymorphes de n-methyle-n-(3-{3-[2-thienylcarbonyle]-pyrazole-[1,5-.alpha.]pyrimidine-7-yl}phenyle)acetamide, compositions et procedes connexes | |
IL160076A0 (en) | Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process | |
IL159281A0 (en) | Process for the production of n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) | |
SI1560830T1 (sl) | Derivati (6,7-dihidro-5H-imidazo(1,2-alfa)imidazol-3-sulfonilamino)-propionamida in njihova uporaba kot inhibitorji interakcije CAM in levkointegrinov | |
EP1344768A3 (fr) | Synthèse de pyrazolopyrimidines substituées | |
GB2425309A (en) | C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers | |
WO2006070244A3 (fr) | Processus de preparation de zaleplon | |
DE60309159D1 (de) | Verfahren zur herstellung von zaleplon | |
TW200630368A (en) | Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto | |
WO2008068600A3 (fr) | Procédé amélioré de préparation du zaléplon | |
ZA200201349B (en) | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl} phenyl)acetamide and compositions and methods related thereto. | |
UY27955A1 (es) | Polimorfo novedoso del n-metil-n-(3-(3-(2- tienilcarbonil) - pirazol- (1,5-o)- pirimidina =7-yl)fenil) acetamida y compuestos y metodos relacionados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20230828 |